Haven Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Haven Capital Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$343K	Hold	5,958	–	–	0.28%	31
2026 Q1	$361K	Sell	5,958 -65	-1%	-$3.79K	0.34%	30
2025 Q4	$325K	Sell	6,023 -1,816	-23%	-$87.4K	0.3%	29
2025 Q3	$354K	Hold	7,839	–	–	0.32%	29
2025 Q2	$363K	Sell	7,839 -825	-10%	-$40.5K	0.32%	32
2025 Q1	$528K	Sell	8,664 -412	-5%	-$24K	0.58%	24
2024 Q4	$513K	Buy	+9,076	New	+$507K	0.48%	28

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Haven Capital Group's BMY Position: Q2 2026 in Review

Haven Capital Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 5,958 shares worth $343K. The position accounts for 0.28% of the portfolio, ranked #31.

Haven Capital Group first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $528K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Haven Capital Group held 5,958 shares of Bristol-Myers Squibb worth $343K as of Q2 2026.
Haven Capital Group left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.28% of Haven Capital Group's portfolio in Q2 2026, its #31 holding.
Haven Capital Group first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Haven Capital Group's Bristol-Myers Squibb position peaked at $528K in Q1 2025.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Haven Capital Group's 13F filing for Q2 2026, filed 10 Jul 2026.